Company / Capital Expenditures
Q32 Bio Inc. Capital Expenditures History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$75.0K
FY2025
5-year range
$5.0K / $3.7M
FY2021-FY2025
Trend
+1400.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures changed +1400% YoY in FY2025, a notable deviation from the 7-year average annual change of +328%.
Based on SEC 10-K filings.
$75,000 in FY2025 with a 5-year CAGR of -67.8%.
Declined from $1M to $75,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -68.5%
- 5-Year CAGR
- -67.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -67.8%, indicating a declining trend.
- In FY2025, capital expenditures increased 1400.0% year-over-year.
- Peak capital expenditures was recorded in FY2019.
- Lowest capital expenditures in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $75.0K | +1400.0% |
| FY2024 | $5.0K | -99.6% |
| FY2023 | $1.3M | -46.4% |
| FY2022 | $2.4M | -35.8% |
| FY2021 | $3.7M | -82.9% |
| FY2020 | $21.8M | -12.5% |
| FY2019 | $24.9M | +1173.7% |
| FY2018 | $2.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026